Literature DB >> 18640385

Using mass measurements in tracer studies--a systematic approach to efficient modeling.

Rajasekhar Ramakrishnan1, Janak D Ramakrishnan.   

Abstract

Tracer enrichment data are fitted by multicompartmental models to estimate rate constants and fluxes or transport rates. In apolipoprotein turnover studies, mass measurements are also available, for example, apolipoprotein B levels in very low-density lipoprotein, intermediate-density lipoprotein, and low-density lipoprotein, and are often essential to calculate some of the rate constants. The usual method to use mass measurements is to estimate pool masses along with rate constants. A systematic alternative approach is developed to use flux balances around pools to express some rate constants in terms of the other rate constants and the measured masses. The resulting reduction in the number of parameters to be estimated makes the modeling more efficient. In models that would be unidentifiable without mass measurements, the usual approach and the proposed approach yield identical results. In a simple two-pool model, the number of unknown parameters is reduced from 4 to 2. In a published five-pool model for apolipoprotein B kinetics with three mass measurements, the number of parameters is reduced from 12 to 9. With m mass measurements, the number of responses to be fitted and the number of parameters to be estimated are each reduced by m, a simplification by 1/4 to 1/3 in a typical pool model. Besides a proportionate reduction in computational effort, there is a further benefit because the dimensionality of the problem is also decreased significantly, which means ease of convergence and a smaller likelihood of suboptimal solutions. Although our approach is conceptually straightforward, the dependencies get considerably more complex with increasing model size. To generate dependency definitions automatically, a Web-accessible program is available at http://biomath.info/poolfit/constraints.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640385      PMCID: PMC2601710          DOI: 10.1016/j.metabol.2008.03.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  38 in total

1.  Theorems on linear systems.

Authors:  J Z HEARON
Journal:  Ann N Y Acad Sci       Date:  1963-05-10       Impact factor: 5.691

2.  A Proof of the Occupancy Principle and the Mean-Transit-Time Theorem for Compartmental Models.

Authors:  Rajasekhar Ramakrishnan; Edward F Leonard; Ralph B Dell
Journal:  Math Biosci       Date:  1984-02-01       Impact factor: 2.144

3.  Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.

Authors:  F K Welty; A H Lichtenstein; P H Barrett; G G Dolnikowski; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

4.  Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.

Authors:  Björn Lundahl; Camilla Skoglund-Andersson; Muriel Caslake; Dorothy Bedford; Philip Stewart; Anders Hamsten; Christopher J Packard; Fredrik Karpe
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-15       Impact factor: 4.310

5.  An Application of Berman's Work on Pool-Model Invariants in Analyzing Indistinguishable Models for Whole-Body Cholesterol Metabolism.

Authors:  Rajasekhar Ramakrishnan
Journal:  Math Biosci       Date:  1984-12       Impact factor: 2.144

Review 6.  Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.

Authors:  D M Foster; P H Barrett; G Toffolo; W F Beltz; C Cobelli
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

7.  Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.

Authors:  Chunyu Zheng; Christina Khoo; Katsunori Ikewaki; Frank M Sacks
Journal:  J Lipid Res       Date:  2007-02-21       Impact factor: 5.922

8.  Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

Authors:  Y Arad; R Ramakrishnan; H N Ginsberg
Journal:  J Lipid Res       Date:  1990-04       Impact factor: 5.922

9.  Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.

Authors:  B W Walsh; F M Sacks
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 10.  Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.

Authors:  P Hugh R Barrett; Gerald F Watts
Journal:  Curr Opin Lipidol       Date:  2003-02       Impact factor: 4.776

View more
  4 in total

1.  Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism.

Authors:  Gissette Reyes-Soffer; Carol Sztalryd; Richard B Horenstein; Stephen Holleran; Anastasiya Matveyenko; Tiffany Thomas; Renu Nandakumar; Colleen Ngai; Wahida Karmally; Henry N Ginsberg; Rajasekhar Ramakrishnan; Toni I Pollin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

2.  A state space transformation can yield identifiable models for tracer kinetic studies with enrichment data.

Authors:  Rajasekhar Ramakrishnan; Janak D Ramakrishnan
Journal:  Bull Math Biol       Date:  2010-03-03       Impact factor: 1.758

3.  Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.

Authors:  Gissette Reyes-Soffer; Byoung Moon; Antonio Hernandez-Ono; Marija Dionizovik-Dimanovski; Marija Dionizovick-Dimanovski; Jhonsua Jimenez; Joseph Obunike; Tiffany Thomas; Colleen Ngai; Nelson Fontanez; Daniel S Donovan; Wahida Karmally; Stephen Holleran; Rajasekhar Ramakrishnan; Robert S Mittleman; Henry N Ginsberg
Journal:  Sci Transl Med       Date:  2016-01-27       Impact factor: 17.956

4.  Gaussian Process Modeling of Protein Turnover.

Authors:  Mahbubur Rahman; Stephen F Previs; Takhar Kasumov; Rovshan G Sadygov
Journal:  J Proteome Res       Date:  2016-06-09       Impact factor: 4.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.